Search Results 401-410 of 23344 for B cell lymphomas
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
B · B-cell lymphoma · Basal cell carcinoma · Bladder cancer · Bone cancer · Bone metastasis · Brain metastases · Brain tumor · Brainstem tumor.
... cell lymphoma that he has recruited through a separate study. ... B., Ph.D., is researching whether use of ... B., Ph.D., is researching whether low ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
Topics include recurrent brachial neuritis in B-cell lymphoma, intractable hiccups in leptomeningeal lymphoplasmacytic lymphoma, and catastrophic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.